EC Ophthalmology

Research Article Volume 14 Issue 8 - 2023

Retinal Vein Occlusion: Epidemiological, Clinical and Therapeutic Aspects at the CADES/O

Baldé Abdoul Karim1,2*, Baldé AI1, Maxim DS1,3, Houssou MD1, Bah TM1,2, Diané S1, Ly M2, Kolié D2 and Daddy U2

1Faculty of Health Sciences and Techniques, Guinea
2Application Center for the Diploma of Specialized Studies in Ophthalmology, Guinea
3Bartimé Hospital, Guinea

*Corresponding Author: Baldé Abdoul Karim, Faculty of Health Sciences and Techniques, Guinea.
Received: July 14, 2023; Published: July 24, 2023




Introduction: The aim of this study was to contribute to the study of the epidemiological, clinical and therapeutic aspects of retinal vein occlusions (RVOs).

Materials and Methods: This was a descriptive cross-sectional study covering a 6-month period from 01 July 2022 to 31 December 2022.

Results: During the study period, out of 3612 patients received at CADESSO, we recorded 23 cases of RVOT, i.e. 6.3%. The mean age was 55.17 years, with extremes of 25 and 72 years. The sex ratio was 1.3 in favour of men. The main reasons for consultation were visual acuity decline (VAD) (69.5%) and visual blur (56.5%). Glaucoma was the most common ophthalmological antecedent in our patients (21.7%). Arterial hypertension (60.8%), diabetes (34.7%) and stress (17.4%) were the most common general antecedents. Among our patients, 16 (70%) had a CRVO and 7 (30%) had an RVO. On OCT, 17 (73.9%) of the patients had macular oedema. Intravitreal injections (65.2%) of anti-VEGF and/or corticosteroids and argon laser (26%) were the most commonly used therapeutic practices.

Conclusion: RVO is a major cause of visual impairment. Prompt, appropriate treatment and management of risk factors can improve visual prognosis.

Keyword: OVR; Risk Factors; Treatment; CADES/O; Guinea

  1. Ip M. Review of retinal vein occlusion (2017).
  2. Gabriel CDP. “Retinal venous occlusions”. Report of the French Society of Ophthalmology (1978): XVII.
  3. Pierru A., et al. “Retinalvein occlusions”. Journal Français d'Ophtalmologie8 (2017): 696-705.
  4. Song P., et al. “Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors”. Journal of Global Health (2019).
  5. Keel S., et al. “Prevalence of retinal vein occlusion in the Australian National Eye Health Survey: Retinal vein occlusion in Australia”. Clinical and Experimental Ophthalmology3 (2018): 260-265.
  6. Thapa R., et al. “Prevalence, pattern and risk factors of retinal vein occlusion in an elderly population in Nepal: the Bhaktapur retina study”. BMC Ophthalmology (2017).
  7. Li JQ., et al. “Prevalence of Retinal Vein Occlusion in Europe: A Systematic Review and Meta-Analysis”. Ophthalmologica4 (2019): 183-189.
  8. Koki G., et al. “Retinal vein occlusions treated with intravitreal injections of bevacizumab at the Yaoundé armed forces training, application and reference hospital”. Journal Français d'Ophtalmologie1 (2020): 51-58.
  9. Fiebai B., et al. “Incidence and risk factors for retinal vein occlusion at the University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria”. Nigerian Journal of Clinical Practice 17 (2014): 462-466.
  10. Uhumwangho OM and Oronsaye D. “Retinal Vein Occlusion in Benin City, Nigeria”. Nigerian Journal of Surgery 1 (2016): 17-20.
  11. Koki G., et al. “Epidemiology and clinic of Retinal Vein Occlusions in Cameroonian hospitals”. Health Sciences and Disease 19 (2018).
  12. Ajayi IA., et al. “Demographic Characteristics and Management Challenges of Retinal Vein Occlusion in Ekiti State, Nigeria”. Journal of Health Science 7 (2017): 33-37.
  13. JQ Zhou., et al. “The ten year incidence and risk factors of retinal vein occlusion: the Beijing eye study”. Journal of Ophthalmology (2013).
  14. Ayena DK., et al. “Therapeutic results of retinal vein occlusions in Lomé after a 5-year follow-up”. Médecine d'Afrique Noire Électronique- Bienvenue 6 (2009): 351-355.
  15. Gaudric A., et al. “Occlusions of retinal venous branches”. In: Cohen S Y et Gaudric A, edition. Rétine. Paris: Médecine Sciences Publication (2012): 114-129.
  16. Prager F., et al. “Intravitreal bevacizumab (avastin) for macular oedema secondary to retinal vein occlusion: 12- month results of a prospective clinical trial”. British Journal of Ophthalmology 93 (2009): 452-456.
  17. Ajayi IA., et al. “Demographic Characteristics and Management Challenges of Retinal Vein Occlusion in Ekiti State, Nigeria”. Journal of Health Science 7 (2017): 33-37.
  18. Glacet-Bernard and Martinet V. “Macula edema in retinal vein occlusion: correlation study between optical coherence tomography, fluorescein angiography and visual acuity”. ARVO (2008).
  19. K Vonor., et al. “Retinal vascular occlusions in Lomé”. Journal Français d'Ophtalmologie 38 (2015): e163-e168.

Baldé Abdoul Karim., et al. Retinal Vein Occlusion: Epidemiological, Clinical and Therapeutic Aspects at the CADES/O. EC Ophthalmology 14.8 (2023): 01-09.

ECronicon Journal

Our Services

Quick Links

Information

Creative Commons LicenseOpen Access by ECronicon is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at www.ecronicon.net